Symbol="EVLO"
AssetType="Common Stock"
Name="Evelo Biosciences Inc"
Description="Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1694665"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="620 MEMORIAL DRIVE, SUITE 200 WEST, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="131340000"
EBITDA="-91120000"
PERatio="None"
PEGRatio="None"
BookValue="-8.24"
DividendPerShare="0"
DividendYield="0"
EPS="-18.77"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.876"
ReturnOnEquityTTM="-62.33"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-18.77"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="22.31"
EVToRevenue="-"
EVToEBITDA="-1.714"
Beta="1.573"
num_52WeekHigh="52.9"
num_52WeekLow="1.586"
num_50DayMovingAverage="6.29"
num_200DayMovingAverage="15.07"
SharesOutstanding="18789700"
DividendDate="None"
ExDividendDate="None"
symbol="EVLO"
open="6.89"
high="7.10"
low="6.53"
price="6.94"
volume="226012.00"
latest_trading_day="2023-08-21"
previous_close="6.99"
change="-0.05"
change_percent="-0.7153%"
aroon_positive_momentum_days="24"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="24"
Volume_recent_avg="7237181"
Change_recent_avg="0.06"
Delta_recent_avg="0.62"
Variance_recent_avg="0.31"
Change_ratio_recent_avg="-3.78"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="24"
Aroon_momentum_negative="76"
image_negative_thumbnail_id_1="1088"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_negative_thumbnail_id_2="173"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="662"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0046.jpeg"
image_positive_thumbnail_id_2="984"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0146.jpeg"
image_professor_thumbnail_id_1="1193"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
